{
 "drug": "Lorazepam Injection",
 "asOf": "2026-08-25",
 "status": "in-shortage",
 "since": "05/03/2018",
 "dayN": 3036,
 "cat": "Neurology",
 "companies": [
  "Hospira, Inc., a Pfizer Company",
  "Hikma Pharmaceuticals USA, Inc.",
  "Amphastar Pharmaceuticals, Inc.",
  "Fresenius Kabi USA, LLC"
 ],
 "reasons": [
  "Demand increase for the drug",
  "Other"
 ],
 "records": [
  {
   "update_type": "Revised",
   "initial_posting_date": "05/03/2018",
   "package_ndc": "0409-1985-30",
   "generic_name": "Lorazepam Injection",
   "contact_info": "844-646-4398",
   "availability": "Limited Availability",
   "related_info": "Limited Supply Available. Next Delivery and Estimated Recovery: September 2026",
   "openfda": {
    "application_number": [
     "ANDA074243"
    ],
    "brand_name": [
     "LORAZEPAM"
    ],
    "generic_name": [
     "LORAZEPAM"
    ],
    "manufacturer_name": [
     "Hospira, Inc."
    ],
    "product_ndc": [
     "0409-1985",
     "0409-1539"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAMUSCULAR",
     "INTRAVENOUS"
    ],
    "substance_name": [
     "LORAZEPAM"
    ],
    "rxcui": [
     "763028",
     "763029"
    ],
    "spl_id": [
     "0280cc35-0696-4091-a000-2314f292feb2"
    ],
    "spl_set_id": [
     "20140b19-846b-425f-b191-670e17809945"
    ],
    "package_ndc": [
     "0409-1539-03",
     "0409-1539-31",
     "0409-1985-03",
     "0409-1985-30"
    ],
    "nui": [
     "N0000175694",
     "M0002356"
    ],
    "pharm_class_epc": [
     "Benzodiazepine [EPC]"
    ],
    "pharm_class_cs": [
     "Benzodiazepines [CS]"
    ],
    "unii": [
     "O26FZP769L"
    ]
   },
   "update_date": "08/07/2026",
   "therapeutic_category": [
    "Neurology"
   ],
   "dosage_form": "Injection",
   "presentation": "Lorazepam, Injection, 2 mg/1 mL Syringes (NDC 0409-1985-30)",
   "company_name": "Hospira, Inc., a Pfizer Company",
   "shortage_reason": "Demand increase for the drug",
   "status": "Current"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "09/05/2018",
   "package_ndc": "0641-6003-25",
   "generic_name": "Lorazepam Injection",
   "contact_info": "800-631-2174",
   "availability": "Unavailable",
   "related_info": "Estimated recovery: TBD",
   "openfda": {
    "application_number": [
     "NDA018140"
    ],
    "brand_name": [
     "ATIVAN"
    ],
    "generic_name": [
     "LORAZEPAM"
    ],
    "manufacturer_name": [
     "Hikma Pharmaceuticals USA Inc."
    ],
    "product_ndc": [
     "0641-6003",
     "0641-6002",
     "0641-6001",
     "0641-6000"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAMUSCULAR",
     "INTRAVENOUS"
    ],
    "substance_name": [
     "LORAZEPAM"
    ],
    "rxcui": [
     "206819",
     "206820",
     "238100",
     "238101",
     "1665188",
     "1665190",
     "1665326",
     "1665327"
    ],
    "spl_id": [
     "209b0091-c890-4f69-a693-d0594c2606fe"
    ],
    "spl_set_id": [
     "5fc0e987-61c9-40c4-b0d5-fcea07c8733e"
    ],
    "package_ndc": [
     "0641-6003-01",
     "0641-6003-25",
     "0641-6002-01",
     "0641-6002-10",
     "0641-6001-01",
     "0641-6001-25",
     "0641-6000-01",
     "0641-6000-10"
    ],
    "nui": [
     "N0000175694",
     "M0002356"
    ],
    "pharm_class_epc": [
     "Benzodiazepine [EPC]"
    ],
    "pharm_class_cs": [
     "Benzodiazepines [CS]"
    ],
    "unii": [
     "O26FZP769L"
    ]
   },
   "update_date": "08/13/2026",
   "therapeutic_category": [
    "Neurology"
   ],
   "dosage_form": "Injection",
   "presentation": "Ativan, Injection, 4 mg/1 mL (NDC 0641-6003-25)",
   "company_name": "Hikma Pharmaceuticals USA, Inc.",
   "shortage_reason": "Other",
   "status": "Current"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "09/05/2018",
   "package_ndc": "0641-6044-25",
   "generic_name": "Lorazepam Injection",
   "contact_info": "800-631-2174",
   "availability": "Limited Availability",
   "related_info": "Lots are being manufactured to meet demand",
   "openfda": {
    "application_number": [
     "NDA018140"
    ],
    "brand_name": [
     "LORAZEPAM"
    ],
    "generic_name": [
     "LORAZEPAM"
    ],
    "manufacturer_name": [
     "Hikma Pharmaceuticals USA Inc."
    ],
    "product_ndc": [
     "0641-6044",
     "0641-6046",
     "0641-6045",
     "0641-6047"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAMUSCULAR",
     "INTRAVENOUS"
    ],
    "substance_name": [
     "LORAZEPAM"
    ],
    "rxcui": [
     "238100",
     "238101",
     "1665188",
     "1665326"
    ],
    "spl_id": [
     "7c73dbc6-2623-4443-9b05-97dec7a0be2e"
    ],
    "spl_set_id": [
     "e9b54e42-04cf-4c62-90e1-36f7b31a4e81"
    ],
    "package_ndc": [
     "0641-6044-01",
     "0641-6044-25",
     "0641-6046-01",
     "0641-6046-10",
     "0641-6045-01",
     "0641-6045-25",
     "0641-6047-01",
     "0641-6047-10"
    ],
    "nui": [
     "N0000175694",
     "M0002356"
    ],
    "pharm_class_epc": [
     "Benzodiazepine [EPC]"
    ],
    "pharm_class_cs": [
     "Benzodiazepines [CS]"
    ],
    "unii": [
     "O26FZP769L"
    ]
   },
   "update_date": "08/13/2026",
   "therapeutic_category": [
    "Neurology"
   ],
   "dosage_form": "Injection",
   "presentation": "Lorazepam, Injection, 2 mg/1 mL (NDC 0641-6044-25)",
   "company_name": "Hikma Pharmaceuticals USA, Inc.",
   "shortage_reason": "Demand increase for the drug",
   "status": "Current"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "09/05/2018",
   "package_ndc": "0641-6001-25",
   "generic_name": "Lorazepam Injection",
   "contact_info": "800-631-2174",
   "availability": "Limited Availability",
   "related_info": "Lots are being manufactured to meet demand",
   "openfda": {
    "application_number": [
     "NDA018140"
    ],
    "brand_name": [
     "ATIVAN"
    ],
    "generic_name": [
     "LORAZEPAM"
    ],
    "manufacturer_name": [
     "Hikma Pharmaceuticals USA Inc."
    ],
    "product_ndc": [
     "0641-6001",
     "0641-6003",
     "0641-6002",
     "0641-6000"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAMUSCULAR",
     "INTRAVENOUS"
    ],
    "substance_name": [
     "LORAZEPAM"
    ],
    "rxcui": [
     "206819",
     "206820",
     "238100",
     "238101",
     "1665188",
     "1665190",
     "1665326",
     "1665327"
    ],
    "spl_id": [
     "209b0091-c890-4f69-a693-d0594c2606fe"
    ],
    "spl_set_id": [
     "5fc0e987-61c9-40c4-b0d5-fcea07c8733e"
    ],
    "package_ndc": [
     "0641-6003-01",
     "0641-6003-25",
     "0641-6002-01",
     "0641-6002-10",
     "0641-6001-01",
     "0641-6001-25",
     "0641-6000-01",
     "0641-6000-10"
    ],
    "nui": [
     "N0000175694",
     "M0002356"
    ],
    "pharm_class_epc": [
     "Benzodiazepine [EPC]"
    ],
    "pharm_class_cs": [
     "Benzodiazepines [CS]"
    ],
    "unii": [
     "O26FZP769L"
    ]
   },
   "update_date": "08/13/2026",
   "therapeutic_category": [
    "Neurology"
   ],
   "dosage_form": "Injection",
   "presentation": "Ativan, Injection, 2 mg/1 mL (NDC 0641-6001-25)",
   "company_name": "Hikma Pharmaceuticals USA, Inc.",
   "shortage_reason": "Demand increase for the drug",
   "status": "Current"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "09/05/2018",
   "package_ndc": "0641-6045-25",
   "generic_name": "Lorazepam Injection",
   "contact_info": "800-631-2174",
   "availability": "Unavailable",
   "related_info": "Estimated recovery: TBD",
   "openfda": {
    "application_number": [
     "NDA018140"
    ],
    "brand_name": [
     "LORAZEPAM"
    ],
    "generic_name": [
     "LORAZEPAM"
    ],
    "manufacturer_name": [
     "Hikma Pharmaceuticals USA Inc."
    ],
    "product_ndc": [
     "0641-6045",
     "0641-6044",
     "0641-6046",
     "0641-6047"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAMUSCULAR",
     "INTRAVENOUS"
    ],
    "substance_name": [
     "LORAZEPAM"
    ],
    "rxcui": [
     "238100",
     "238101",
     "1665188",
     "1665326"
    ],
    "spl_id": [
     "7c73dbc6-2623-4443-9b05-97dec7a0be2e"
    ],
    "spl_set_id": [
     "e9b54e42-04cf-4c62-90e1-36f7b31a4e81"
    ],
    "package_ndc": [
     "0641-6044-01",
     "0641-6044-25",
     "0641-6046-01",
     "0641-6046-10",
     "0641-6045-01",
     "0641-6045-25",
     "0641-6047-01",
     "0641-6047-10"
    ],
    "nui": [
     "N0000175694",
     "M0002356"
    ],
    "pharm_class_epc": [
     "Benzodiazepine [EPC]"
    ],
    "pharm_class_cs": [
     "Benzodiazepines [CS]"
    ],
    "unii": [
     "O26FZP769L"
    ]
   },
   "update_date": "08/13/2026",
   "therapeutic_category": [
    "Neurology"
   ],
   "dosage_form": "Injection",
   "presentation": "Lorazepam, Injection, 4 mg/1 mL (NDC 0641-6045-25)",
   "company_name": "Hikma Pharmaceuticals USA, Inc.",
   "shortage_reason": "Other",
   "status": "Current"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "09/05/2018",
   "package_ndc": "0641-6000-10",
   "generic_name": "Lorazepam Injection",
   "contact_info": "800-631-2174",
   "availability": "Unavailable",
   "related_info": "Estimated recovery: TBD",
   "openfda": {
    "application_number": [
     "NDA018140"
    ],
    "brand_name": [
     "ATIVAN"
    ],
    "generic_name": [
     "LORAZEPAM"
    ],
    "manufacturer_name": [
     "Hikma Pharmaceuticals USA Inc."
    ],
    "product_ndc": [
     "0641-6000",
     "0641-6003",
     "0641-6002",
     "0641-6001"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAMUSCULAR",
     "INTRAVENOUS"
    ],
    "substance_name": [
     "LORAZEPAM"
    ],
    "rxcui": [
     "206819",
     "206820",
     "238100",
     "238101",
     "1665188",
     "1665190",
     "1665326",
     "1665327"
    ],
    "spl_id": [
     "209b0091-c890-4f69-a693-d0594c2606fe"
    ],
    "spl_set_id": [
     "5fc0e987-61c9-40c4-b0d5-fcea07c8733e"
    ],
    "package_ndc": [
     "0641-6003-01",
     "0641-6003-25",
     "0641-6002-01",
     "0641-6002-10",
     "0641-6001-01",
     "0641-6001-25",
     "0641-6000-01",
     "0641-6000-10"
    ],
    "nui": [
     "N0000175694",
     "M0002356"
    ],
    "pharm_class_epc": [
     "Benzodiazepine [EPC]"
    ],
    "pharm_class_cs": [
     "Benzodiazepines [CS]"
    ],
    "unii": [
     "O26FZP769L"
    ]
   },
   "update_date": "08/13/2026",
   "therapeutic_category": [
    "Neurology"
   ],
   "dosage_form": "Injection",
   "presentation": "Ativan, Injection, 2 mg/1 mL (NDC 0641-6000-10)",
   "company_name": "Hikma Pharmaceuticals USA, Inc.",
   "shortage_reason": "Other",
   "status": "Current"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "09/05/2018",
   "package_ndc": "0641-6002-10",
   "generic_name": "Lorazepam Injection",
   "contact_info": "800-631-2174",
   "availability": "Unavailable",
   "related_info": "Estimated recovery: TBD",
   "openfda": {
    "application_number": [
     "NDA018140"
    ],
    "brand_name": [
     "ATIVAN"
    ],
    "generic_name": [
     "LORAZEPAM"
    ],
    "manufacturer_name": [
     "Hikma Pharmaceuticals USA Inc."
    ],
    "product_ndc": [
     "0641-6002",
     "0641-6003",
     "0641-6001",
     "0641-6000"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAMUSCULAR",
     "INTRAVENOUS"
    ],
    "substance_name": [
     "LORAZEPAM"
    ],
    "rxcui": [
     "206819",
     "206820",
     "238100",
     "238101",
     "1665188",
     "1665190",
     "1665326",
     "1665327"
    ],
    "spl_id": [
     "209b0091-c890-4f69-a693-d0594c2606fe"
    ],
    "spl_set_id": [
     "5fc0e987-61c9-40c4-b0d5-fcea07c8733e"
    ],
    "package_ndc": [
     "0641-6003-01",
     "0641-6003-25",
     "0641-6002-01",
     "0641-6002-10",
     "0641-6001-01",
     "0641-6001-25",
     "0641-6000-01",
     "0641-6000-10"
    ],
    "nui": [
     "N0000175694",
     "M0002356"
    ],
    "pharm_class_epc": [
     "Benzodiazepine [EPC]"
    ],
    "pharm_class_cs": [
     "Benzodiazepines [CS]"
    ],
    "unii": [
     "O26FZP769L"
    ]
   },
   "update_date": "08/13/2026",
   "therapeutic_category": [
    "Neurology"
   ],
   "dosage_form": "Injection",
   "presentation": "Ativan, Injection, 4 mg/1 mL (NDC 0641-6002-10)",
   "company_name": "Hikma Pharmaceuticals USA, Inc.",
   "shortage_reason": "Other",
   "status": "Current"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "05/03/2018",
   "package_ndc": "76329-8261-1",
   "generic_name": "Lorazepam Injection",
   "contact_info": "800-423-4136",
   "availability": "Available",
   "openfda": {
    "application_number": [
     "ANDA076150"
    ],
    "brand_name": [
     "LORAZEPAM"
    ],
    "generic_name": [
     "LORAZEPAM"
    ],
    "manufacturer_name": [
     "International Medication Systems, Limited"
    ],
    "product_ndc": [
     "76329-8261"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAMUSCULAR",
     "INTRAVENOUS"
    ],
    "substance_name": [
     "LORAZEPAM"
    ],
    "rxcui": [
     "238100"
    ],
    "spl_id": [
     "b85a6695-55b9-4780-a803-33f8f2464138"
    ],
    "spl_set_id": [
     "7dda070d-7809-46c4-8592-eb4e4c509707"
    ],
    "package_ndc": [
     "76329-8261-1"
    ],
    "nui": [
     "N0000175694",
     "M0002356"
    ],
    "pharm_class_epc": [
     "Benzodiazepine [EPC]"
    ],
    "pharm_class_cs": [
     "Benzodiazepines [CS]"
    ],
    "unii": [
     "O26FZP769L"
    ]
   },
   "update_date": "08/18/2026",
   "therapeutic_category": [
    "Neurology"
   ],
   "dosage_form": "Injection",
   "presentation": "Lorazepam, Injection, 2 mg/1 mL (NDC 76329-8261-1)",
   "company_name": "Amphastar Pharmaceuticals, Inc.",
   "status": "Current"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "09/05/2018",
   "package_ndc": "0641-6046-10",
   "generic_name": "Lorazepam Injection",
   "contact_info": "800-631-2174",
   "availability": "Unavailable",
   "related_info": "Estimated recovery: TBD",
   "openfda": {
    "application_number": [
     "NDA018140"
    ],
    "brand_name": [
     "LORAZEPAM"
    ],
    "generic_name": [
     "LORAZEPAM"
    ],
    "manufacturer_name": [
     "Hikma Pharmaceuticals USA Inc."
    ],
    "product_ndc": [
     "0641-6046",
     "0641-6044",
     "0641-6045",
     "0641-6047"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAMUSCULAR",
     "INTRAVENOUS"
    ],
    "substance_name": [
     "LORAZEPAM"
    ],
    "rxcui": [
     "238100",
     "238101",
     "1665188",
     "1665326"
    ],
    "spl_id": [
     "7c73dbc6-2623-4443-9b05-97dec7a0be2e"
    ],
    "spl_set_id": [
     "e9b54e42-04cf-4c62-90e1-36f7b31a4e81"
    ],
    "package_ndc": [
     "0641-6044-01",
     "0641-6044-25",
     "0641-6046-01",
     "0641-6046-10",
     "0641-6045-01",
     "0641-6045-25",
     "0641-6047-01",
     "0641-6047-10"
    ],
    "nui": [
     "N0000175694",
     "M0002356"
    ],
    "pharm_class_epc": [
     "Benzodiazepine [EPC]"
    ],
    "pharm_class_cs": [
     "Benzodiazepines [CS]"
    ],
    "unii": [
     "O26FZP769L"
    ]
   },
   "update_date": "08/13/2026",
   "therapeutic_category": [
    "Neurology"
   ],
   "dosage_form": "Injection",
   "presentation": "Lorazepam, Injection, 2 mg/1 mL (NDC 0641-6046-10)",
   "company_name": "Hikma Pharmaceuticals USA, Inc.",
   "shortage_reason": "Other",
   "status": "Current"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "05/03/2018",
   "package_ndc": "65219-368-02",
   "generic_name": "Lorazepam Injection",
   "contact_info": "888-386-1300",
   "availability": "Available",
   "related_info": "Check wholesalers for inventory",
   "openfda": {
    "application_number": [
     "ANDA217598"
    ],
    "brand_name": [
     "LORAZEPAM"
    ],
    "generic_name": [
     "LORAZEPAM"
    ],
    "manufacturer_name": [
     "Fresenius Kabi USA, LLC"
    ],
    "product_ndc": [
     "65219-368"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAMUSCULAR",
     "INTRAVENOUS"
    ],
    "substance_name": [
     "LORAZEPAM"
    ],
    "rxcui": [
     "1665188"
    ],
    "spl_id": [
     "5cd2d0d8-9639-4e96-aafd-4991ad35fabc",
     "462a13da-259a-40e7-bd5b-f7f42ae025b7"
    ],
    "spl_set_id": [
     "b2487467-a63f-48b5-b0de-3a6ce6672d50",
     "462a13da-259a-40e7-bd5b-f7f42ae025b7"
    ],
    "package_ndc": [
     "65219-368-01",
     "65219-368-02",
     "65219-368-14",
     "65219-368-24"
    ],
    "nui": [
     "N0000175694",
     "M0002356"
    ],
    "pharm_class_epc": [
     "Benzodiazepine [EPC]"
    ],
    "pharm_class_cs": [
     "Benzodiazepines [CS]"
    ],
    "unii": [
     "O26FZP769L"
    ]
   },
   "update_date": "08/04/2026",
   "therapeutic_category": [
    "Neurology"
   ],
   "dosage_form": "Injection",
   "presentation": "Lorazepam, Injection, 2 mg/1 mL (NDC 65219-368-02)",
   "company_name": "Fresenius Kabi USA, LLC",
   "status": "Current"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "05/03/2018",
   "package_ndc": "0641-6047-10",
   "generic_name": "Lorazepam Injection",
   "contact_info": "800-631-2174",
   "availability": "Unavailable",
   "related_info": "Estimated recovery: TBD",
   "openfda": {
    "application_number": [
     "NDA018140"
    ],
    "brand_name": [
     "LORAZEPAM"
    ],
    "generic_name": [
     "LORAZEPAM"
    ],
    "manufacturer_name": [
     "Hikma Pharmaceuticals USA Inc."
    ],
    "product_ndc": [
     "0641-6047",
     "0641-6044",
     "0641-6046",
     "0641-6045"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAMUSCULAR",
     "INTRAVENOUS"
    ],
    "substance_name": [
     "LORAZEPAM"
    ],
    "rxcui": [
     "238100",
     "238101",
     "1665188",
     "1665326"
    ],
    "spl_id": [
     "7c73dbc6-2623-4443-9b05-97dec7a0be2e"
    ],
    "spl_set_id": [
     "e9b54e42-04cf-4c62-90e1-36f7b31a4e81"
    ],
    "package_ndc": [
     "0641-6044-01",
     "0641-6044-25",
     "0641-6046-01",
     "0641-6046-10",
     "0641-6045-01",
     "0641-6045-25",
     "0641-6047-01",
     "0641-6047-10"
    ],
    "nui": [
     "N0000175694",
     "M0002356"
    ],
    "pharm_class_epc": [
     "Benzodiazepine [EPC]"
    ],
    "pharm_class_cs": [
     "Benzodiazepines [CS]"
    ],
    "unii": [
     "O26FZP769L"
    ]
   },
   "update_date": "08/13/2026",
   "therapeutic_category": [
    "Neurology"
   ],
   "dosage_form": "Injection",
   "presentation": "Lorazepam, Injection, 4 mg/1 mL (NDC 0641-6047-10)",
   "company_name": "Hikma Pharmaceuticals USA, Inc.",
   "shortage_reason": "Other",
   "status": "Current"
  }
 ]
}